NAS10026,944+1.18%S&P7,385+0.42%GOLD$4,067−1.12%BTC$75,586−0.47%VIX25.28−10.29%latest tape · as of 18:01 UTC
The Screen · Industrials · Aerospace & Defense
CWCurtiss-Wright Corp
CW · the NYSE · USD · Market cap $17.6B · 9,100 employees
Curtiss-Wright Corporation, together with its subsidiaries, provides engineered products, solutions, and services mainly to aerospace and defense, commercial nuclear power, process, and industrial markets worldwide.
FAIL · Does not pass the screen
433.87 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price433.87 USD at the 5 Nov 2026 close
Our value readFair vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.37, read 2026-11-03
Ethical does not pass the values gate
Price433.87 USD
Fair value493.36
Ethical score30.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Distribution532.36-18.5% to today ✓Markdown gives way to Distribution
2026-10-02Read Markdown532.36-18.5% to today ✓Distribution gives way to Markdown after a 16% slide in 5 weeks
2026-08-26Read Distribution634.99-31.7% to today ✓Markup gives way to Distribution after a 16% slide in 8 weeks
2026-07-02Read Markup758.00-42.8% to today First review on file: Markup with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Curtiss-Wright Corp holds its Distribution at $433.87. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$433.87
Valuation
32.78 trailing · 27.62 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.88
The Workings
Five Screens, Shown in Full
Does not pass. Excluded industry: Aerospace & Defense
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Excluded industry: Aerospace & Defense
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Curtiss-Wright does not clear the screen at the business-activity stage. It operates in aerospace and defense, so the financial ratios are not the deciding factor here.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CW's ethical verdict changes
Today CW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades at roughly an 8% discount to our $493.36 fair value, narrow competitive moat, 5.40% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 12.1% discount to the base estimate.
Where our models see it going: fair-value estimate $493.36, with a range of $466.20 to $567.36, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Defence supplier fails ethics and valuation test
Supplying parts that end up inside military jets or nuclear plants gives Curtiss-Wright steady work, yet the business sits on the wrong side of our ethical screen from the outset.
We pass because the aerospace and defence exposure triggers an outright exclusion and the shares already price in perfection at 41 times forward earnings against our lower fair value. Revenue growth of 13 percent and a 20 percent return on equity look respectable on paper but do not offset the premium valuation or the narrow moat.
Even the analyst consensus target above the current price cannot change the fact that peak-cycle earnings in defence often look cheap on a low multiple only to disappoint later. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CW trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Distribution$497.76+4.6%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Distribution$476.01+0.0%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Distribution$476.01+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Distribution$476.01+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$476.01-0.3%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$477.49+2.7%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$464.94-7.4%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Distribution$502.32+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$502.32+0.0%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788.
2026-10-18Distribution$502.32-5.6%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (6 analysts) rates it buy, with a mean price target of $788.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.